JP2004537554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537554A5 JP2004537554A5 JP2003513970A JP2003513970A JP2004537554A5 JP 2004537554 A5 JP2004537554 A5 JP 2004537554A5 JP 2003513970 A JP2003513970 A JP 2003513970A JP 2003513970 A JP2003513970 A JP 2003513970A JP 2004537554 A5 JP2004537554 A5 JP 2004537554A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- optionally substituted
- phenyl
- pharmaceutical composition
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30662101P | 2001-07-19 | 2001-07-19 | |
| PCT/US2002/022897 WO2003008411A1 (en) | 2001-07-19 | 2002-07-18 | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537554A JP2004537554A (ja) | 2004-12-16 |
| JP2004537554A5 true JP2004537554A5 (enExample) | 2006-01-05 |
Family
ID=23186103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003513970A Ceased JP2004537554A (ja) | 2001-07-19 | 2002-07-18 | 置換されたピペラジン化合物および脂肪酸酸化インヒビターとしてのその使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6930111B2 (enExample) |
| EP (1) | EP1406898B1 (enExample) |
| JP (1) | JP2004537554A (enExample) |
| KR (1) | KR100919141B1 (enExample) |
| CN (1) | CN1533388A (enExample) |
| AT (1) | ATE292633T1 (enExample) |
| AU (1) | AU2008202958A1 (enExample) |
| CA (1) | CA2454059A1 (enExample) |
| DE (1) | DE60203623T2 (enExample) |
| DK (1) | DK1406898T3 (enExample) |
| ES (1) | ES2236557T3 (enExample) |
| HU (1) | HUP0402088A3 (enExample) |
| IL (1) | IL159897A0 (enExample) |
| MX (1) | MXPA04000565A (enExample) |
| NO (1) | NO327635B1 (enExample) |
| NZ (1) | NZ530705A (enExample) |
| PL (1) | PL368529A1 (enExample) |
| PT (1) | PT1406898E (enExample) |
| RU (1) | RU2300533C2 (enExample) |
| WO (1) | WO2003008411A1 (enExample) |
| ZA (1) | ZA200400404B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7001909B2 (en) * | 2001-07-19 | 2006-02-21 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
| CN100551370C (zh) * | 2002-05-21 | 2009-10-21 | Cv医药有限公司 | 雷诺嗪在制备治疗糖尿病的药物组合物中的应用 |
| US8822473B2 (en) | 2002-05-21 | 2014-09-02 | Gilead Sciences, Inc. | Method of treating diabetes |
| WO2004014902A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
| AR040847A1 (es) | 2002-08-09 | 2005-04-20 | Astrazeneca Ab | 1,2,4-oxadiazoles como moduladores de receptores de glutamato metabotropicos, para el tratamiento de desordenes neurologicos y psiquiatricos |
| TW200424183A (en) * | 2002-08-09 | 2004-11-16 | Nps Pharma Inc | New compounds |
| EP1806346B1 (en) * | 2002-12-05 | 2009-07-22 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| ES2287574T3 (es) * | 2002-12-05 | 2007-12-16 | Cv Therapeutics, Inc. | Compuestos de piperacina sustituidos y su utilizacion como inhibidores de la oxidacion de acidos grasos. |
| KR20050086956A (ko) | 2003-01-03 | 2005-08-30 | 씨브이 쎄러퓨틱스, 인코포레이티드 | 치환된 복소환 화합물 |
| AU2004209522A1 (en) * | 2003-01-17 | 2004-08-19 | Gilead Palo Alto, Inc. | Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| EP1644345A1 (en) * | 2003-06-23 | 2006-04-12 | Cv Therapeutics, Inc. | Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| KR20060124646A (ko) * | 2003-12-18 | 2006-12-05 | 씨브이 쎄러퓨틱스, 인코포레이티드 | 1-아칸-2-올 치환된 피페라진 및 피페리딘 화합물 |
| EP1699527A1 (en) * | 2004-01-02 | 2006-09-13 | Advanced Cardiovascular Systems, Inc. | High-density lipoprotein coated medical devices |
| JP2008512465A (ja) * | 2004-09-08 | 2008-04-24 | シーブイ・セラピューティクス・インコーポレイテッド | 脂肪酸酸化阻害剤としての置換ピペラジン化合物およびその使用 |
| EP2056844A4 (en) | 2006-08-24 | 2010-11-24 | Wockhardt Research Center | NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT |
| US8088920B2 (en) * | 2008-03-31 | 2012-01-03 | Hoffmann-La Roche Inc. | 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents |
| SMT202000257T1 (it) * | 2008-10-10 | 2020-07-08 | Vm Discovery Inc | Composizioni e metodi per il trattamento dei disturbi da uso di alcol, dolore e altre malattie |
| CA2761771A1 (en) * | 2009-05-14 | 2010-11-18 | Gilead Sciences, Inc. | Ranolazine for the treatment of cns disorders |
| JPWO2011115150A1 (ja) * | 2010-03-18 | 2013-07-04 | 興和株式会社 | ベンゾチアジン化合物の製造方法 |
| CN111285819A (zh) * | 2018-12-07 | 2020-06-16 | 江苏恩华药业股份有限公司 | 一种苯并噁唑类化合物及其应用 |
| WO2023023995A1 (zh) * | 2021-08-25 | 2023-03-02 | 苏州大学 | 一种防治心肌缺血后心功能衰竭的药物及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1133989A (en) | 1964-12-08 | 1968-11-20 | Chugai Pharmaceutical Co Ltd | Theophylline derivatives, their salts and process for preparing the same |
| DE2834114A1 (de) * | 1978-08-01 | 1980-02-14 | Schering Ag | Polyalkoxyphenylpyrrolidone iii, verfahren zu ihrer herstellung und ihre verwendung |
| US4567264A (en) * | 1983-05-18 | 1986-01-28 | Syntex (U.S.A.) Inc. | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
| JPS6137765A (ja) * | 1984-07-19 | 1986-02-22 | サンド・アクチエンゲゼルシヤフト | ３‐アミノプロポキシアリール誘導体 |
| US4723014A (en) * | 1986-11-19 | 1988-02-02 | Warner-Lambert Company | Process for the preparation of 2-substituted-1,4-dihydropyridines |
| DE3723648A1 (de) * | 1987-07-17 | 1989-01-26 | Sandoz Ag | Indol-derivate, ihre herstellung und sie enthaltende arzneimittel |
| JPH0699399B2 (ja) * | 1988-10-06 | 1994-12-07 | 三井東圧化学株式会社 | 新規複素環化合物およびそれを有効成分として含有する製癌剤効果増強剤 |
| JPH02268162A (ja) * | 1989-04-10 | 1990-11-01 | Fujisawa Pharmaceut Co Ltd | ジフェニルピリジン誘導体 |
| MX9308025A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. |
| WO1998021190A1 (en) * | 1996-11-14 | 1998-05-22 | American Home Products Corporation | Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents |
| EP1212335B1 (en) * | 1999-09-13 | 2006-01-18 | Wyeth | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| SE9904765D0 (sv) | 1999-12-23 | 1999-12-23 | Astra Ab | Pharmaceutically-useful compounds |
| CA2400176C (en) * | 2000-02-22 | 2009-04-28 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| AU2001239827A1 (en) * | 2000-02-22 | 2001-09-03 | Cv Therapeutics, Inc. | Substituted alkylene diamine compounds |
| WO2001062749A1 (en) | 2000-02-22 | 2001-08-30 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| US6552023B2 (en) | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
| US6451798B2 (en) | 2000-02-22 | 2002-09-17 | Cv Therapeutics, Inc. | Substituted alkyl piperazine derivatives |
| SE0003795D0 (sv) * | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Pharmaceutically useful compounds |
| US6573264B1 (en) | 2000-10-23 | 2003-06-03 | Cv Therapeutics, Inc. | Heteroaryl alkyl piperazine derivatives |
-
2002
- 2002-07-18 DK DK02756522T patent/DK1406898T3/da active
- 2002-07-18 NZ NZ530705A patent/NZ530705A/en not_active IP Right Cessation
- 2002-07-18 CN CNA02814371XA patent/CN1533388A/zh active Pending
- 2002-07-18 RU RU2004104951/04A patent/RU2300533C2/ru not_active IP Right Cessation
- 2002-07-18 MX MXPA04000565A patent/MXPA04000565A/es active IP Right Grant
- 2002-07-18 CA CA002454059A patent/CA2454059A1/en not_active Abandoned
- 2002-07-18 IL IL15989702A patent/IL159897A0/xx unknown
- 2002-07-18 AT AT02756522T patent/ATE292633T1/de not_active IP Right Cessation
- 2002-07-18 US US10/198,237 patent/US6930111B2/en not_active Expired - Fee Related
- 2002-07-18 WO PCT/US2002/022897 patent/WO2003008411A1/en not_active Ceased
- 2002-07-18 ES ES02756522T patent/ES2236557T3/es not_active Expired - Lifetime
- 2002-07-18 PT PT02756522T patent/PT1406898E/pt unknown
- 2002-07-18 HU HU0402088A patent/HUP0402088A3/hu unknown
- 2002-07-18 EP EP02756522A patent/EP1406898B1/en not_active Expired - Lifetime
- 2002-07-18 DE DE60203623T patent/DE60203623T2/de not_active Expired - Fee Related
- 2002-07-18 JP JP2003513970A patent/JP2004537554A/ja not_active Ceased
- 2002-07-18 KR KR1020047000898A patent/KR100919141B1/ko not_active Expired - Fee Related
- 2002-07-18 PL PL02368529A patent/PL368529A1/xx not_active Application Discontinuation
-
2004
- 2004-01-19 ZA ZA200400404A patent/ZA200400404B/en unknown
- 2004-01-19 NO NO20040234A patent/NO327635B1/no not_active IP Right Cessation
-
2008
- 2008-07-03 AU AU2008202958A patent/AU2008202958A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004104951A (ru) | Замещенные пиперазиновые соединения и их применение в качестве ингибиторов окисления жирных кислот | |
| JP2015533157A5 (enExample) | ||
| JP2013519680A5 (enExample) | ||
| EP2712616B1 (en) | Intermediates for the preparation of 1-(acetyl)-piperidine and 1-(acetyl)-piperazine derivatives as fungicides for use in plant protection | |
| RU2379299C2 (ru) | Производные 5-(бенз-(z)-илиден)тиазолидин-4-она и их применение в качестве иммуносупрессорных агентов | |
| JP2009525984A5 (enExample) | ||
| JP2004534035A5 (enExample) | ||
| JP2006506340A5 (enExample) | ||
| JP2009519965A5 (enExample) | ||
| RU2009102537A (ru) | Ингибиторы белок-тирозинфосфатазы человека и способы применения | |
| JP2005526815A5 (enExample) | ||
| RU2004127928A (ru) | Производные морфолинилмочевины для использования в лечении воспалительных заболеваний | |
| RU2383524C2 (ru) | Гексафторизопропанол-замещенные производные простых эфиров | |
| JP2018535999A5 (enExample) | ||
| JP2006503081A5 (enExample) | ||
| JP2010513319A5 (enExample) | ||
| JP2010513397A5 (enExample) | ||
| JP2004517080A5 (enExample) | ||
| JP2009544742A5 (enExample) | ||
| JP2006517572A5 (enExample) | ||
| JP2006502134A5 (enExample) | ||
| JP2007510713A5 (enExample) | ||
| RU2006119623A (ru) | Аллостерические модуляторы метаботропных глутаматных рецепторов | |
| JP2007523905A5 (enExample) | ||
| JP2007523142A5 (enExample) |